0      0

AONN+ Midyear 2022

SAT02 - COSELA™: A Novel Myeloprotection therapy| Presentation by G1 Therapeutics

May 14, 2022 9:45am ‐ May 14, 2022 10:45am


A Novel Myeloprotection Therapy

In this presentation, Ms. Bukolt will: 

Review the burden and current treatment landscape of chemotherapy-induced myelosuppression

Introduce the mechanism of action and key efficacy and safety data of the first and only proactive multilineage myeloprotection therapy for patients with extensive-stage small cell lung cancer

Explore adverse reactions, dosing and administration and the G1 to One™ patient support program


You must be logged in and own this session in order to post comments.